Confirming it has reached 3 million weekly developers, OpenAI is massively updating its Codex developer environment via its Mac and Windows desktop apps today to bring it closer to the “Super App” the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when reading this story: The brain uses two key pathways for ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

A new study finds that certain patterns of AI use are driving cognitive fatigue, while others can help reduce burnout. by Julie Bedard, Matthew Kropp, Megan Hsu, Olivia T. Karaman, Jason Hawes and ...

🛍️ Amazon Big Spring Sale: 100+ editor-approved deals worth buying right now 🛍️ By Stack Commerce Published Mar 2, 2026 7:00 AM EST Add Popular Science (opens in a new tab) Adding us as a Preferred ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Liza Minnelli claims she was forced to sit in a wheelchair while she presented at the 2022 Academy Awards. Minnelli, now 79, took the stage that night alongside Lady Gaga as her co-presenter to ...

Pranay Parab is an independent tech journalist based in Mumbai, India. He covers tech for Lifehacker, and specializes in tutorials and in-depth features. Apple Music is testing a new AI playlist ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...